Japanese chemical industry news (page 4)

• 

  28 November 2025

  Sendai Biomass Power Plant by Sumitomo and Partners Begins Operations

  The Sendai Biomass Plant, with 112 MW output, uses certified wood fuels to support carbon neutrality and renewable energy in Tohoku, Japan.
• 

  27 November 2025

  Braskem and Katoen Natie Launch Singapore Warehouse Project

  The warehouse in Singapore will enhance logistics for bio-based products in Southeast Asia, optimizing supply chain performance and reducing transport routes.
• 

  26 November 2025

  Toray Unveils New Bonding Material for Ultra-Thin Semiconductor Wafers

  New bonding material enables thinner semiconductor wafers, enhancing AI, NAND, and power semiconductor performance while reducing environmental impact. Mass production set for 2028.
• 

  25 November 2025

  Toray Licenses Drug Candidate for Peripheral Neuropathy Treatment

  Sanodyne gains rights to develop TRK-750 for neuropathy. SNT-001 shows promise in trials, with Phase II planned. Collaboration aims to advance treatment options.
• 

  20 November 2025

  ORLEN Group Reports Record Q3 2025 Profit and Investment

  ORLEN's Q3 2025 saw high investment in energy security, record dividends, and growth in renewable capacity, with strong performance across all segments despite challenging conditions.
• 

  14 November 2025

  Asahi Kasei Wins 2025 Best IR Award from JIRA

  Recognized for proactive IR efforts, Asahi Kasei excels in investor dialogue, integrated reporting, and leveraging intangible assets across its business sectors.

• 

  13 November 2025

  LanzaJet Produces Commercial-Scale Jet Fuel from Ethanol

  LanzaJet's ATJ technology converts ethanol to jet fuel, marking a breakthrough in sustainable aviation fuel, enhancing energy security, and supporting global decarbonization efforts.
• 

  13 November 2025

  Toray Divests Stake in Japan Vilene

  Toray sells its 25% stake to Freudenberg for ¥17 billion. The deal finalizes in February 2026, with a ¥6 billion post-tax gain expected. Toray will continue supplying products to Japan Vilene.
• 

  13 November 2025

  FRONTEO and UBE Partner for AI-Driven Drug Discovery Research

  The collaboration aims to enhance drug discovery by combining AI for target identification with compound optimization, reducing R&D risks and accelerating processes.
• 

  13 November 2025

  Asahi Kasei's Planova FG1 Wins BioTech Innovation Award

  Planova FG1 filter enhances biologics production with high permeability and virus retention, boosting efficiency and sustainability in biomanufacturing.
• 

  7 November 2025

  Takeda's Mezagitamab Maintains Kidney Function in IgAN After 18 Months

  Mezagitamab shows stable eGFR, reduced proteinuria, and no serious adverse events in IgAN patients 18 months post-treatment; Phase 3 trials are underway.
• 

  7 November 2025

  AGC's Reflective Blade Wins CES 2026 Innovation Award

  Reflective Blade projects driver info clearly, even with polarized sunglasses, offers flexible integration, and enhances user experience with a sleek design.
• 

  6 November 2025

  Boehringer Ingelheim's Apecotrep Reduces Proteinuria in Phase II Kidney Trial

  Apecotrep, a TRPC6 inhibitor, showed 40% proteinuria reduction in FSGS patients. Phase III trial recruiting; further Phase II trials planned for other kidney diseases.
• 

  6 November 2025

  Lilly Expands Leadership Team for Growth

  Lilly appoints Carole Ho and Adrienne Brown to Executive Committee, expands roles for Daniel Skovronsky and Jacob Van Naarden to drive growth in neuroscience and immunology.
• 

  6 November 2025

  Mitsubishi Gas Chemical and Transition Industries Sign Ultra-Low Carbon Methanol Agreement

  The agreement secures 1 million tons/year of ultra-low carbon methanol from 2029, supporting decarbonization and sustainability in Japan and Asia.
• 

  5 November 2025

  Toray and Aichi Medical University Launch ALS Drug Research Initiative

  The initiative uses a new evaluation technology to enhance ALS drug discovery, collaborating with pharmaceutical firms to improve treatment efficacy and accelerate R&D.
• 

  4 November 2025

  Asahi Kasei Licenses Electrolyte Tech to EAS Batteries for New High-Power Cell

  The new cell uses acetonitrile electrolyte for better performance in demanding applications, with plans for global sublicensing to expand into mobility markets.
• 

  30 October 2025

  Boehringer Ingelheim Licenses Autoimmune Treatment from Kyowa Kirin

  Boehringer gains exclusive rights to develop a small molecule for autoimmune diseases, with potential payments to Kyowa Kirin up to €640 million.
• 

  30 October 2025

  Toray Unveils Carbon Fiber Recycling Tech Retaining Strength and Quality

  New recycling tech decomposes CFRP, retaining fiber strength and quality, enabling diverse applications like nonwoven fabrics for cars, electronics, and more, while reducing CO2 emissions.
• 

  29 October 2025

  Johnson & Johnson to Conduct Study Comparing IMAAVY™ and Alternative FcRn Blocker for gMG

  The EPIC study will compare IMAAVY™ to efgartigimod in gMG patients, including a treatment-switch arm. Vibrance-MG data shows sustained IgG reduction and disease control in pediatric patients.
• 

  29 October 2025

  Merck and Eisai Update on LEAP-012 Trial for Hepatocellular Carcinoma

  The LEAP-012 trial showed no overall survival benefit for the treatment, but progression-free survival improved. The study is closed, and further data analysis is ongoing.
• 

  28 October 2025

  Merck's KEYTRUDA and WELIREG Combo Improves DFS in RCC Patients Post-Nephrectomy

  The LITESPARK-022 trial shows improved DFS with KEYTRUDA and WELIREG in RCC patients. Safety profiles align with previous studies. Results to be shared with regulators.
• 

  28 October 2025

  Merck and Eisai's WELIREG and LENVIMA Improve PFS in Advanced Renal Cell Carcinoma Trial

  The trial showed significant PFS and ORR improvements with WELIREG and LENVIMA in advanced RCC patients post anti-PD-1/L1 therapy, with consistent safety profiles.
• 

  26 October 2025

  Hyundai and Toray Partner on Advanced Mobility Materials

  The firms signed a joint agreement to develop advanced composite materials for future mobility, focusing on R&D, production, and commercialization.
• 

  24 October 2025

  Johnson & Johnson: Nipocalimab Reduces Sjögren’s Disease Activity and Severity

  Nipocalimab shows promise in reducing Sjögren’s disease symptoms and autoantibodies, with a favorable safety profile and ongoing Phase 3 trials.
• 

  24 October 2025

  AGC and NPC Partner for Solar Panel Glass Recycling Expansion

  Aiming to recycle solar panel glass by 2030, a new method turns cover glass into architectural glass, overcoming technical challenges and enhancing sustainability.
• 

  24 October 2025

  Evonik Opens New Aluminum Specialty Plant in Japan

  Evonik's new plant in Japan boosts local production of advanced fumed alumina, enhancing supply security, sustainability, and customer proximity in Asia.
• 

  23 October 2025

  Asahi Kasei Expands Electrolysis Component Production for Clean Hydrogen

  New facilities at Kawasaki Works will boost production of electrolysis components, supporting clean hydrogen and chlor-alkali markets, backed by Japan's GX Supply Chain Development Program.
• 

  21 October 2025

  Takeda Partners with Innovent on Oncology Medicines

  Takeda gains rights to two late-stage cancer drugs and an option for an early-stage program, focusing on global development and commercialization outside Greater China.
• 

  20 October 2025

  Perpetual Next Appoints Gervais Green to Supervisory Board, Continues Partnership with ING Corporate Finance

  Gervais Green joins to enhance governance and international growth. Collaboration with Fluor and ING supports biomethanol expansion and strategic partner admission.